GATTEI, VALTER
 Distribuzione geografica
Continente #
EU - Europa 787
NA - Nord America 580
AS - Asia 462
SA - Sud America 70
AF - Africa 19
OC - Oceania 2
Totale 1.920
Nazione #
US - Stati Uniti d'America 551
RU - Federazione Russa 248
SG - Singapore 168
IT - Italia 134
IE - Irlanda 111
CN - Cina 77
DE - Germania 73
SE - Svezia 64
VN - Vietnam 60
BR - Brasile 59
HK - Hong Kong 58
FR - Francia 43
IN - India 40
GB - Regno Unito 29
UA - Ucraina 22
PL - Polonia 18
CA - Canada 15
BD - Bangladesh 10
FI - Finlandia 10
MX - Messico 10
KR - Corea 8
LT - Lituania 7
AT - Austria 6
BJ - Benin 6
AR - Argentina 5
ID - Indonesia 5
JP - Giappone 5
TR - Turchia 5
ZA - Sudafrica 5
CZ - Repubblica Ceca 4
IQ - Iraq 4
NL - Olanda 4
UZ - Uzbekistan 4
EG - Egitto 3
ES - Italia 3
GR - Grecia 3
HR - Croazia 3
KE - Kenya 3
PK - Pakistan 3
CO - Colombia 2
KG - Kirghizistan 2
MY - Malesia 2
OM - Oman 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
BE - Belgio 1
BG - Bulgaria 1
CH - Svizzera 1
CL - Cile 1
CR - Costa Rica 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
GE - Georgia 1
IL - Israele 1
JM - Giamaica 1
JO - Giordania 1
KZ - Kazakistan 1
LB - Libano 1
MD - Moldavia 1
PA - Panama 1
PH - Filippine 1
PS - Palestinian Territory 1
TN - Tunisia 1
TO - Tonga 1
TW - Taiwan 1
ZM - Zambia 1
Totale 1.920
Città #
Dublin 110
San Jose 86
Singapore 62
Ashburn 61
Hong Kong 57
Jacksonville 41
Beijing 38
Moscow 24
Lauterbourg 23
Ho Chi Minh City 22
Los Angeles 20
Novara 20
Warsaw 17
Boardman 15
Piemonte 15
Vercelli 15
Lawrence 14
Milan 14
Princeton 14
São Paulo 14
New York 13
Chandler 12
Dearborn 12
Munich 11
Hanoi 9
Atlanta 8
Bremen 8
Denver 8
Falkenstein 8
Helsinki 8
Orem 8
Seoul 8
Frankfurt am Main 7
Mexico City 7
Montreal 7
Podenzano 7
Redondo Beach 7
Turin 7
Buffalo 6
Chennai 6
Cotonou 6
London 6
Manchester 6
Santa Clara 6
Belo Horizonte 5
Hillsboro 5
Roseto degli Abruzzi 5
Tokyo 5
Wilmington 5
Ann Arbor 4
Boston 4
Chicago 4
Council Bluffs 4
Da Nang 4
Dallas 4
Hangzhou 4
Nuremberg 4
Seattle 4
Somaglia 4
Stockholm 4
Tornaco 4
Toronto 4
Ankara 3
Athens 3
Brno 3
Brooklyn 3
City of London 3
Grafing 3
Gunzenhausen 3
Jackson 3
Johannesburg 3
Palermo 3
Poplar 3
San Mateo 3
Sorocaba 3
Tashkent 3
Vilnius 3
Amsterdam 2
Cagliari 2
Cologno Monzese 2
Hackney 2
Houston 2
Istanbul 2
Jakarta 2
Lewisham 2
Mosul 2
Norwalk 2
Rimini 2
Rio de Janeiro 2
Rome 2
Roubaix 2
San Francisco 2
Santana do Araguaia 2
St Louis 2
Suzano 2
Thái Bình 2
Turku 2
Vienna 2
Zagreb 2
Abadia de Goiás 1
Totale 1.040
Nome #
Immunoglobulin light chain mutational status refines IGHV prognostic value in identifying chronic lymphocytic leukemia patients with early treatment requirement 129
A B-cell receptor-related gene signature predicts survival in mantle cell lymphoma: results from the "Fondazione Italiana Linfomi" MCL-0208 trial 127
Mutational status of IGHV is the most reliable prognostic marker in trisomy 12 chronic lymphocytic leukemia 105
Molecular clustering on ctDNA improves the prognostic stratification of DLBCL patients compared to ctDNA levels 105
HIF-1α is overexpressed in leukemic cells from TP53-disrupted patients and is a promising therapeutic target in chronic lymphocytic leukemia 103
Survival risk score for real-life relapsed/refractory chronic lymphocytic leukemia patients receiving ibrutinib. A campus CLL study 103
Mutations in the 3′ untranslated region of NOTCH1 are associated with low CD20 expression levels in chronic lymphocytic leukemia 101
CD49d promotes disease progression in chronic lymphocytic leukemia: new insights from CD49d bimodal expression 100
NOTCH1 mutations are associated with high CD49d expression in chronic lymphocytic leukemia: link between the NOTCH1 and the NF-κB pathways 90
Assessment of the 4-factor score: Retrospective analysis of 586 CLL patients receiving ibrutinib. A campus CLL study 89
XPO1 mutations identify early‐stage CLL characterized by shorter time to first treatment and enhanced BCR signalling 86
Effectiveness of ibrutinib as first-line therapy for chronic lymphocytic leukemia patients and indirect comparison with rituximab-bendamustine: Results of study on 486 cases outside clinical trials 84
Comparison of ibrutinib and idelalisib plus rituximab in real-life relapsed/resistant chronic lymphocytic leukemia cases 84
Validation of a survival-risk score (SRS) in relapsed/refractory CLL patients treated with idelalisib–rituximab 82
TP53 disruption as a risk factor in the era of targeted therapies: A multicenter retrospective study of 525 chronic lymphocytic leukemia cases 80
Quality assessment for PCR-based minimal residual disease in Lymphoma: 10 Years of cross-laboratory standardization process within the fondazione italiana linfomi MRD network 76
Elastin MIcrofibriL INterfacer1 (EMILIN-1) is an alternative prosurvival VLA-4 ligand in chronic lymphocytic leukemia 73
Local radiotherapy and measurable residual disease-driven immunotherapy in patients with early-stage follicular lymphoma (FIL MIRO): final results of a prospective, multicentre, phase 2 trial 68
Integration of [18F]FDG-PET radiomics with liquid biopsy improves outcome prediction in newly diagnosed diffuse large B-cell lymphoma 61
CD49d expression is included in a revised 4‐factor model predicting outcome in patients with chronic lymphocytic leukemia treated with ibrutinib: A multicenter real‐world experience 53
Efficacy of front‐line ibrutinib versus fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: A retrospective multicenter “Real‐World” study 49
The VLA-4 integrin is constitutively active in circulating chronic lymphocytic leukemia cells via BCR autonomous signaling: a novel anchor-independent mechanism exploiting soluble blood-borne ligands 47
A comprehensive genetic study of classic Hodgkin lymphoma using circulating tumor DNA 39
Dissecting clonal hematopoiesis in the myeloid compartment of chronic lymphocytic leukemia and Richter transformation 18
Totale 1.952
Categoria #
all - tutte 9.391
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.391


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202111 0 0 0 0 0 0 0 0 0 3 8 0
2021/202257 0 0 3 4 5 0 3 0 4 2 14 22
2022/2023212 15 13 17 0 10 15 7 15 109 1 3 7
2023/2024106 8 13 9 6 13 1 16 0 0 0 10 30
2024/2025328 7 0 9 2 11 14 41 79 66 21 14 64
2025/20261.079 51 40 53 128 173 104 154 194 95 87 0 0
Totale 1.952